These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1615796)

  • 1. Determinants of the renal response to ACE inhibition in patients with congestive heart failure.
    Gottlieb SS; Robinson S; Weir MR; Fisher ML; Krichten CM
    Am Heart J; 1992 Jul; 124(1):131-6. PubMed ID: 1615796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal morphology and function in dogs after treatment with the angiotensin-converting enzyme inhibitor quinapril.
    Susick RL; Dominick MA; Ulloa HM; Pegg DG
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):275-82. PubMed ID: 7511758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
    Endlich K; Steinhausen M
    J Hypertens; 1997 Jun; 15(6):633-41. PubMed ID: 9218183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
    Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
    Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure.
    Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL
    J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
    Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
    Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.
    Osei SY; Price DA; Fisher ND; Porter L; Laffel LM; Hollenberg NK
    Hypertension; 1999 Jan; 33(1 Pt 2):559-64. PubMed ID: 9931165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
    Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
    Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.
    Kawai H; Stevens SY; Liang CS
    Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H3012-9. PubMed ID: 11087259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
    Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
    Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans.
    Komers R; Komersova K; Kazdova L; Ruzickova J; Pelikanova T
    J Hypertens; 2000 Jan; 18(1):51-9. PubMed ID: 10678543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
    Tietze IN; Sørensen SS; Ivarsen PR; Nielsen CB; Pedersen EB
    J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal structure and function in rats after suprapharmacologic doses of quinapril, an angiotensin-converting enzyme inhibitor.
    MacDonald JR; Susick RL; Pegg DG; Dominick MA
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):282-9. PubMed ID: 1376798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.